Key result
Pharmacist-led medication reconciliation identified 152 discrepancies among 73 patients (74 in the intervention group, 78 in control), with physicians accepting 64.86% of pharmacist recommendations.
Why the study?
Medication discrepancies frequently occur across transitions of care, motivating an assessment of the impact of pharmacist interventions during care transitions and related perceptions.
Does pharmacist-led medication reconciliation reduce unresolved medication discrepancies in adult patients with chronic diseases during hospital transitions?
RCT (n=73)
randomized
No
Does pharmacist-led medication reconciliation reduce unresolved medication discrepancies in adult patients with chronic diseases during hospital transitions?
Pharmacist-led medication reconciliation during hospital transitions effectively identifies and resolves medication discrepancies with high acceptance from physicians and satisfaction from patients.
Answers are grounded in this paper and cite their sources.
Pharmacist-led reconciliation may resolve discrepancies during transitions; leaves open impact on clinical outcomes in larger trials.
AIM: The study aimed to assess the impact of pharmacist interventions during the transition of care. BACKGROUND: Medication discrepancies can occur at various levels of transition, such as during admission, the transition from emergency to special wards or from special to general wards, and during discharge. Discrepancies can be detected through the process of medication reconciliation. OBJECTIVE: The objective of the study was to compare discrepancies among patients exposed to pharmacist intervention groups and those who were not and assess the perception of healthcare professionals and patients towards integrating pharmacists in the transition care process. METHODS: A pharmacist-led interventional study was conducted for six months on patients above 18 years of age and either sex who were admitted to the emergency department, had chronic diseases, and subsequently transferred to another department (any). The patients were randomized into intervention and control groups. The pharmacist performed a medication reconciliation and medication review to identify discrepancies in every transition in both the groups, and then reported to the treating physician to resolve in the intervention group. RESULTS: Among the 73 patients recruited in the study, 152 discrepancies were identified. The total discrepancies observed in the control and intervention groups were 78 (51.3%) and 74 (48.6%), respectively. The majority, 35.53%, were found during the transition from emergency to special wards. The physician, upon pharmacist recommendations, accepted and resolved 48 discrepancies in the intervention group. The healthcare professional acceptance rate of pharmacist interventions was 64.86%. CONCLUSION: The transitions of care are at risk for errors due to medication discrepancies, and pharmacists could potentially identify and resolve discrepancies. Healthcare professionals and patients reported to be satisfied by the involvement of clinical pharmacists in the healthcare team.
No takes yet. Share an insight, caveat, or question.
Joseph et al. (2023) conducted an RCT in chronic diseases (n=73). Pharmacist-led medication reconciliation and review vs. Control group (no pharmacist intervention reported to physician) was evaluated on Medication discrepancies. Pharmacist-led medication reconciliation identified 152 discrepancies among 73 patients (74 in the intervention group, 78 in control), with physicians accepting 64.86% of pharmacist recommendations.
Synapse has enriched 10 related papers. Consider them for comparative context: